GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PEBO · Dec 31, 2024

PEOPLES BANCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000318300-25-000093Bank
Sequential deposit growth59thOwn-history percentile · N=17
Evidence method

Sequential · gp.financial.deposits

1.43% · CORE · VALID

Net-income growth17thOwn-history percentile · N=12
Evidence method

Yoy · gp.fundamentals.net_income

3.39% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=12
Evidence method

Yoy · gp.financial.interest_income

18.52% · CORE · VALID

Cash and equivalents39thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.cash

$217.7M · CORE · VALID

Sequential loan growth59thOwn-history percentile · N=17
Evidence method

Sequential · gp.financial.loans

1.44% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History24 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
2.54%
Current
1.43%
Delta
-1.11%
Earnings Growth Increased
Previous
-0.62%
Current
3.39%
Delta
4.01%
Interest Income Growth Increased
Previous
8.11%
Current
18.52%
Delta
10.41%
Liquidity Decreased
Previous
$283.7M
Current
$217.7M
Delta
-$66.0M
Loan Growth Increased
Previous
-0.86%
Current
1.44%
Delta
2.30%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.